Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-19

Clinical Trial Update: Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating lenalidomide in combination with G-CHOP for newly diagnosed diffuse large B-cell lymphoma with follicular lymphoma is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Doxorubicin (doxorubicin)
  • Lenalidomide (lenalidomide)
  • Obinutuzumab (obinutuzumab)
  • PREDNISONE (Prednisone)
  • Vincristine (vincristine)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma | Phase 2 | Status: RECRUITING